Gyrus Capital has agreed to acquire LivaNova’s heart valve business for an enterprise value of €60m.
Thoma Bravo buys back into Flexera at reported $2.85bn valuation, 12 years after $200m buyout
Vidici Ventures et al. in €2m seed round for ReceiptHero